Author:
Kee Chee-Leong,Chin Lee-Cheng,Cheah Nuan-Ping,Ge Xiaowei,Low Min-Yong
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference17 articles.
1. The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione;Daugan;J. Med. Chem.,2003
2. Identification of aminotadalafil and its stereoisomers contained in health foods using chiral liquid chromatography–mass spectrometry;Kurita;J. Health Sci.,2008
3. PDE5 inhibitors: an original access to novel potent arylated analogues of tadalafil;Beghyn;Bioorg. Med. Chem. Lett.,2007
4. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements;Kee;J. Pharm. Biomed. Anal.,2018
5. Identification of a new tadalafil analogue, N-3-hydroxypropylnortadalafil, in a supplement product;Lee;J. Pharm. Biomed. Anal.,2018
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献